INTANGIBLE ASSETS AND GOODWILL (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Goodwill and Intangible Assets Disclosure [Abstract] |
|
| Schedule of indefinite-lived intangible assets |
The major components of intangible assets consist of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted-Average Remaining Useful Lives (Years) | | December 31, 2025 | | December 31, 2024 | | (in millions) | | Gross Carrying Amount | | Accumulated Amortization and Impairments | | Net Carrying Amount | | Gross Carrying Amount | | Accumulated Amortization and Impairments | | Net Carrying Amount | Finite-lived intangible assets: | | | | | | | | | | | | | | | Product brands | 7 | | $ | 4,441 | | | $ | (3,064) | | | $ | 1,377 | | | $ | 4,373 | | | $ | (2,799) | | | $ | 1,574 | | | Corporate brands | 9 | | 102 | | | (26) | | | 76 | | | 102 | | | (18) | | | 84 | | | Product rights/patents | 5 | | 999 | | | (988) | | | 11 | | | 993 | | | (970) | | | 23 | | | Other | 7 | | 87 | | | (68) | | | 19 | | | 79 | | | (64) | | | 15 | | | Total finite-lived intangible assets | | | 5,629 | | | (4,146) | | | 1,483 | | | 5,547 | | | (3,851) | | | 1,696 | | | Acquired in-process research and development intangible asset | N/A | | 100 | | | — | | | 100 | | | 100 | | | — | | | 100 | | | B&L Trademark | N/A | | 1,698 | | | — | | | 1,698 | | | 1,698 | | | — | | | 1,698 | | | | | $ | 7,427 | | | $ | (4,146) | | | $ | 3,281 | | | $ | 7,345 | | | $ | (3,851) | | | $ | 3,494 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of finite-lived intangible assets |
The major components of intangible assets consist of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted-Average Remaining Useful Lives (Years) | | December 31, 2025 | | December 31, 2024 | | (in millions) | | Gross Carrying Amount | | Accumulated Amortization and Impairments | | Net Carrying Amount | | Gross Carrying Amount | | Accumulated Amortization and Impairments | | Net Carrying Amount | Finite-lived intangible assets: | | | | | | | | | | | | | | | Product brands | 7 | | $ | 4,441 | | | $ | (3,064) | | | $ | 1,377 | | | $ | 4,373 | | | $ | (2,799) | | | $ | 1,574 | | | Corporate brands | 9 | | 102 | | | (26) | | | 76 | | | 102 | | | (18) | | | 84 | | | Product rights/patents | 5 | | 999 | | | (988) | | | 11 | | | 993 | | | (970) | | | 23 | | | Other | 7 | | 87 | | | (68) | | | 19 | | | 79 | | | (64) | | | 15 | | | Total finite-lived intangible assets | | | 5,629 | | | (4,146) | | | 1,483 | | | 5,547 | | | (3,851) | | | 1,696 | | | Acquired in-process research and development intangible asset | N/A | | 100 | | | — | | | 100 | | | 100 | | | — | | | 100 | | | B&L Trademark | N/A | | 1,698 | | | — | | | 1,698 | | | 1,698 | | | — | | | 1,698 | | | | | $ | 7,427 | | | $ | (4,146) | | | $ | 3,281 | | | $ | 7,345 | | | $ | (3,851) | | | $ | 3,494 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of estimated aggregate amortization expense for each of the five succeeding years |
Estimated amortization expense of finite-lived intangible assets for the five years ending December 31 and thereafter are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | 2026 | | 2027 | | 2028 | | 2029 | | 2030 | | Thereafter | | Total | | Amortization | | $ | 225 | | | $ | 221 | | | $ | 220 | | | $ | 219 | | | $ | 216 | | | $ | 382 | | | $ | 1,483 | |
|
| Schedule of changes in the carrying amount of goodwill |
The changes in the carrying amounts of goodwill during the years ended 2025, 2024 and 2023 were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Vision Care | | Pharmaceuticals | | Surgical | | Total | Balance, January 1, 2023 | | $ | 3,549 | | | $ | 645 | | | $ | 313 | | | $ | 4,507 | | | Acquisitions (Note 4) | | — | | | 23 | | | 8 | | | 31 | | | Foreign exchange and other | | 7 | | | 25 | | | 5 | | | 37 | | Balance, December 31, 2023 | | 3,556 | | | 693 | | | 326 | | | 4,575 | | | Acquisitions (Note 4) | | — | | | — | | | 29 | | | 29 | | | Foreign exchange and other | | (27) | | | (49) | | | (5) | | | (81) | | Balance, December 31, 2024 | | 3,529 | | | 644 | | | 350 | | | 4,523 | | | Acquisitions (Note 4) | | — | | | — | | | 97 | | | 97 | | | Foreign exchange and other | | 26 | | | 100 | | | 12 | | | 138 | | Balance, December 31, 2025 | | $ | 3,555 | | | $ | 744 | | | $ | 459 | | | $ | 4,758 | |
|